Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 380

1.

Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.

Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T, Fukui S, Sawada K, Fukuda Y, Tamura K, Satomi M, Shimoyama T, Furuyama J.

Immunogenetics. 2002 Mar;53(12):1020-7. Epub 2002 Feb 7.

PMID:
11904678
2.

Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.

Waschke KA, Villani AC, Vermeire S, Dufresne L, Chen TC, Bitton A, Cohen A, Thomson AB, Wild GE.

Am J Gastroenterol. 2005 May;100(5):1126-33.

PMID:
15842589
3.

Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.

Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.

J Pediatr Gastroenterol Nutr. 2006 May;42(5):479-87.

PMID:
16707968
5.

Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease.

Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K.

Genes Immun. 2000 Aug;1(6):351-7.

6.

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.

Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P.

Aliment Pharmacol Ther. 2004 Aug 1;20(3):303-10.

7.

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G.

Immunogenetics. 2003 Jul;55(4):247-52. Epub 2003 Jun 14.

PMID:
12811429
8.

[Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].

Heresbach D, Ababou A, Bourienne A, Alizadeh M, Quelvennec E, Pagenault M, Dabadie A, Berre NH, Campion JP, Launois B, Gosselin M, Genetet B, Bretagne JF, Semana G.

Gastroenterol Clin Biol. 1997;21(8-9):555-61. French.

9.

TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.

Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, Crusius JB.

Int J Immunogenet. 2006 Apr;33(2):81-5.

PMID:
16611251
10.

Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.

Song Y, Wu KC, Zhang L, Hao ZM, Li HT, Zhang LX, Qiao TD, Li CN, Fan DM.

Chin J Dig Dis. 2005;6(4):170-4.

PMID:
16246225
11.

The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.

Cantor MJ, Nickerson P, Bernstein CN.

Am J Gastroenterol. 2005 May;100(5):1134-42.

PMID:
15842590
12.

Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.

Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E, Bok L, Peppelenbosch MP, Faber KN, Kleibeuker JH, Dijkstra G.

Inflamm Bowel Dis. 2008 Dec;14(12):1615-22. doi: 10.1002/ibd.20610.

PMID:
18668679
13.

Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility.

Teramoto M, Kitawaki J, Koshiba H, Kitaoka Y, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Matsushita M, Maruya E, Saji H, Ohta M, Honjo H.

Am J Reprod Immunol. 2004 May;51(5):352-7.

PMID:
15212671
14.

Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.

Cucchiara S, Latiano A, Palmieri O, Canani RB, D'Incà R, Guariso G, Vieni G, De Venuto D, Riegler G, De'Angelis GL, Guagnozzi D, Bascietto C, Miele E, Valvano MR, Bossa F, Annese V; Italian Society of Pediatric Gastroenterology and Nutrition..

J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):171-9.

PMID:
17255827
15.

TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.

Nishimura M, Obayashi H, Mizuta I, Hara H, Adachi T, Ohta M, Tegoshi H, Fukui M, Hasegawa G, Shigeta H, Kitagawa Y, Nakano K, Kaji R, Nakamura N.

Hum Immunol. 2003 Feb;64(2):302-9.

PMID:
12559634
16.

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.

Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.

Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.

PMID:
19455129
17.

Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences.

Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J.

Arthritis Rheum. 2002 Aug;46(8):2045-50.

18.

Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene.

Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, Toyota T.

Gastroenterology. 1999 Nov;117(5):1062-8.

PMID:
10535868
19.

Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease.

Fiedler T, Büning C, Reuter W, Pitre G, Gentz E, Schmidt HH, Büttner J, Ockenga J, Gerloff T, Meisel C, Lochs H, Roots I, Köpke K, Johne A.

Eur J Clin Pharmacol. 2007 Oct;63(10):917-25. Epub 2007 Jul 31.

PMID:
17665184
20.

MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients.

Urcelay E, Mendoza JL, Martín MC, Mas A, Martínez A, Taxonera C, Fernandez-Arquero M, Díaz-Rubio M, de la Concha EG.

Inflamm Bowel Dis. 2006 Jan;12(1):33-7.

PMID:
16374256

Supplemental Content

Support Center